Thanks bella.
Genuinely excited to be able to introduce PromarkerD into clinical practice subsequent to MBS scheduling. After considering the research conducted (I'm planning to virtually attend the ADA Scientific Sessions in early June as well ), IMHO PromarkerD certainly provides a very clear pathway forward for diagnosis and management for doctors. The current system of patient monitoring is fairly ad-hoc and confusing. IMO I have no doubt that patients will be the real beneficiaries of the new testing protocols once introduced. Happy days for all hopefully.
Progress towards MSAC Review, page-3
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
0.010(1.45%) |
Mkt cap ! $91.70M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 70.0¢ | 69.0¢ | $8.726K | 12.58K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11430 | 69.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.5¢ | 16545 | 1 |
View Market Depth
| Last trade - 15.49pm 06/11/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |